DoNotAge Senolytic Bundle (Fisetin + Quercetin)
Best Overall StackDose: Fisetin 500mg + Quercetin 500mg per day
$55–70 / 60-day supply (each)
Quick Comparison
| Product | Key Specs | Price Range | Buy |
|---|---|---|---|
| DoNotAge Senolytic Bundle (Fisetin + Quercetin) Best Overall Stack |
| $55–70 / 60-day supply (each) | Check Price |
| Renue By Science Senolytic Bundle Best Science-Backed Brand |
| $60–75 / 60-day supply | Check Price |
| Double Wood Senolytic Stack Best Value Stack |
| $40–50 / combined 2-month supply | Check Price |
| ProHealth Longevity Senolytic Activator Best Pre-Made Senolytic Formula |
| $45–55 / 30 servings | Check Price |
Contains affiliate links — we may earn a small commission at no extra cost to you.
Best Senolytics Supplement Stack 2026: Fisetin, Quercetin, and Beyond
One of the most compelling concepts in geroscience is that aging is not just wear-and-tear — it’s the accumulation of specific dysfunctional cells that actively accelerate the process. Senescent cells are the central evidence for this theory, and clearing them is one of the most exciting therapeutic frontiers in longevity research.
Pharmaceutical senolytics (dasatinib, navitoclax) are potent but require physician supervision. Natural senolytics — primarily fisetin and quercetin — have genuine preclinical evidence and emerging human pilot data. The right senolytic stack combines them strategically, using an intermittent protocol that mirrors the science.
This article covers the stack concept — the combination approach for natural senolytics. For deep dives on individual compounds:
What Are Senescent Cells and Why Do They Matter?
Cellular senescence is a normal biological process — cells under stress (DNA damage, telomere shortening, oncogenic activation) enter a permanent growth arrest to prevent them from becoming cancerous. This is beneficial when it happens acutely. The problem is what happens when senescent cells accumulate over decades:
The SASP problem: Senescent cells secrete a pro-inflammatory cocktail called the Senescence-Associated Secretory Phenotype (SASP) — a mix of cytokines (IL-6, IL-8), proteases (matrix metalloproteinases), and growth factors that:
- Damage neighboring healthy tissue
- Recruit immune cells causing sterile inflammation
- Promote senescence in nearby cells (“paracrine senescence”)
- Contribute to age-related disease burden (cardiovascular disease, type 2 diabetes, neurodegeneration, osteoarthritis)
The accumulation problem: Young immune systems efficiently clear senescent cells. Aging immune systems lose this capability. By age 60–70, senescent cell burden in tissues has increased substantially, and the SASP load drives much of what we recognize as “inflammaging.”
Why senolytics? Rather than suppressing the SASP (senostatics — another approach), senolytics eliminate the source. In animal models, periodic senescent cell clearance has extended healthspan, reduced frailty, improved organ function, and in some models extended lifespan.
The Science: Natural Senolytic Research
The Fisetin Foundation (EBioMedicine 2018)
The most important natural senolytic paper is Yousefzadeh et al. (2018) from the Kirkland lab at Mayo Clinic, published in EBioMedicine (doi:10.1016/j.ebiom.2018.09.015):
- Tested 10 candidate natural compounds for senolytic potency
- Fisetin was the clear winner — the most potent natural senolytic identified, clearing 25–50% of senescent cells across multiple tissues in aged mice
- Fisetin late in life extended median murine lifespan by ~10% and maximum lifespan by ~15%
- Reduced frailty and improved health metrics in aged mice
The AFFIRM-LITE Trial (Fisetin in Humans — 2021)
Mayo Clinic Phase 1/2 RCT (Nora Bauer et al., clinical trial NCT03675724):
- 20 older women (age 70–90) with elevated senescent cell markers
- Fisetin 20mg/kg × 2 consecutive days (approximately 1,500mg for a 75kg individual)
- Adipose tissue biopsies showed decreased p16 and p21 (senescent cell markers) vs. placebo
- Circulating SASP markers (IL-6, MMP-9) trended downward
- No serious adverse events — first human evidence of in vivo senolytic activity
This is early-stage data — a small pilot — but represents proof-of-concept that fisetin’s mechanism translates from mice to humans.
The Quercetin + Dasatinib (D+Q) Human Trial
The landmark D+Q study in humans (Justice et al., 2019; doi:10.1016/j.ebiom.2019.03.053):
- 14 patients with idiopathic pulmonary fibrosis (IPF) — a fibrotic lung disease with heavy senescent cell burden
- Dasatinib 100mg + Quercetin 1000mg on 3 consecutive days, repeated weekly for 3 weeks
- Significant reductions in SASP markers (circulating senescent cell-derived factors)
- Improved 6-minute walk distance, grip strength, and stair climb speed vs. controls
- This was the first human proof-of-concept for senolytic clearance improving functional outcomes
Quercetin Alone (Natural Context)
Quercetin is less potent as a senolytic than fisetin alone, but contributes complementary activity:
- Targets BCL-XL (quercetin) and BCL-2/BCL-W (fisetin) — different survival proteins on senescent cells
- The stack is synergistic — together they cover more senescent cell types
- Quercetin’s anti-inflammatory effects also suppress SASP even when cells are not fully cleared (senostatic role)
Best Senolytic Supplement Stacks 2026
1. DoNotAge Senolytic Bundle — Best Overall Stack
DoNotAge is a specialized longevity supplement brand with a dedicated focus on the geroscience community. Their fisetin and quercetin products are designed specifically as a senolytic stack, with COAs available for quality verification. Each product is dosed for the intermittent protocol — 500mg fisetin and 500mg quercetin per capsule. For the standard periodic protocol, taking 3–4 capsules of each on 2 consecutive days per month provides 1,500–2,000mg fisetin and 1,500–2,000mg quercetin — the research-informed dose range.
Composite Score: 8.7/10
| Factor | Score | Notes |
|---|---|---|
| Evidence Quality (30%) | 9/10 | High-dose capsules designed for periodic protocol |
| Ingredient Transparency (25%) | 9/10 | COA, single-ingredient products |
| Value (20%) | 7/10 | ~$0.55–0.70/dose (good for the niche) |
| Real-World Performance (15%) | 9/10 | Strong longevity community following |
| Third-Party Verification (10%) | 8/10 | COA available |
2. Renue By Science Senolytic Bundle — Best Science-Backed Brand
Renue By Science takes a particularly research-oriented approach to longevity supplements, often citing specific studies in their formulation rationale. Their senolytic bundle pairs fisetin (500mg) with a higher-dose quercetin (1000mg) per serving — weighting quercetin more heavily, which aligns with the D+Q protocol’s emphasis on quercetin volume. COA available, no fillers. Best for users who want to mirror the Justice et al. quercetin dosing protocol more closely.
Composite Score: 8.5/10
| Factor | Score | Notes |
|---|---|---|
| Evidence Quality (30%) | 9/10 | Higher quercetin dose mirrors D+Q protocol |
| Ingredient Transparency (25%) | 9/10 | Full disclosure, COA available |
| Value (20%) | 6/10 | Premium price tier |
| Real-World Performance (15%) | 8/10 | Strong science-community trust |
| Third-Party Verification (10%) | 8/10 | COA available |
3. Double Wood Senolytic Stack — Best Value
Double Wood offers separate fisetin (100mg capsules) and quercetin (500mg capsules) products that can be purchased together at the best combined cost. The fisetin dose per capsule (100mg) is lower than longevity-focused options — for the periodic high-dose protocol, 15–20 fisetin capsules would be needed for a single session (1,500–2,000mg). More manageable for the daily maintenance approach or users who stack the fisetin slowly. Quercetin at 500mg per capsule is well-dosed for the protocol.
Composite Score: 7.8/10
| Factor | Score | Notes |
|---|---|---|
| Evidence Quality (30%) | 7/10 | Fisetin per-capsule dose is low for high-dose protocol |
| Ingredient Transparency (25%) | 8/10 | COA available, clean labels |
| Value (20%) | 10/10 | Lowest combined cost |
| Real-World Performance (15%) | 8/10 | Strong review volume across both products |
| Third-Party Verification (10%) | 7/10 | COA on request |
4. ProHealth Longevity Senolytic Activator — Best Pre-Made Formula
ProHealth combines fisetin (500mg) and quercetin (500mg) into a single capsule product — the most convenient option for users who don’t want to manage multiple bottles. COA available. The combined formula approach may appeal to users who want simplicity, though it doesn’t allow independent dose adjustment of each component (e.g., if you want more quercetin than fisetin). ProHealth has a long track record in the longevity supplement space.
Composite Score: 8.2/10
| Factor | Score | Notes |
|---|---|---|
| Evidence Quality (30%) | 8/10 | Appropriate doses of both compounds |
| Ingredient Transparency (25%) | 8/10 | Both ingredients and doses stated |
| Value (20%) | 7/10 | ~$1.50–1.83/serving (2 capsules) |
| Real-World Performance (15%) | 8/10 | Good ProHealth brand reputation |
| Third-Party Verification (10%) | 8/10 | COA available |
The Senolytic Stack Protocol
The senolytic benefit requires intermittent high-dose use — not daily supplementation. Senescent cells take weeks to months to re-accumulate after a clearance protocol. Daily low-dose use provides antioxidant and anti-inflammatory benefits but does not trigger the senolytic (cell-clearing) mechanism.
Standard Natural Senolytic Protocol (Research-Informed)
Phase 1: Monthly Burst Protocol
- Day 1 and Day 2 of each month:
- Fisetin: 1,000–2,000mg (divided across 2 doses with fatty meals — fat increases absorption)
- Quercetin: 500–1,000mg (with fisetin doses)
- Timing: Morning and early afternoon doses; fat-containing meals improve polyphenol bioavailability
- Duration: Ongoing — repeat monthly or quarterly based on tolerance and goals
Phase 2: Daily Maintenance (Optional) Some users add a lower daily dose between monthly bursts for ongoing antioxidant and anti-inflammatory benefits:
- Fisetin: 100–250mg/day
- Quercetin: 250–500mg/day
Why Not Every Day?
Senolytic mechanisms (BCL-2 inhibition) at high concentrations can also affect non-senescent cells. The intermittent protocol targets the periods when intracellular concentrations peak — which is when senolytic activity is highest — while allowing normal BCL-2 function between sessions. This is the design rationale used in the Mayo Clinic protocols.
Advanced Stack Additions
Some longevity protocols extend the base fisetin + quercetin stack:
- Alpha-Ketoglutarate (AKG) — Added to the maintenance phase for epigenetic/TCA support (not taken on burst days to avoid interaction)
- Spermidine — Autophagy induction; clears cellular debris after senolytic cell death
- Piperlongumine — Emerging natural senolytic; limited human data but in the research pipeline
How We Score
We evaluate each stack using a 5-factor composite scoring system aligned with our How We Test methodology:
| Factor | Weight | What We Measure |
|---|---|---|
| Evidence Quality | 30% | Per-dose potency for intermittent protocol |
| Ingredient Transparency | 25% | Compounds, doses, and COA availability |
| Value | 20% | Combined cost per monthly burst session |
| Real-World Performance | 15% | Verified purchase reviews, longevity community feedback |
| Third-Party Verification | 10% | NSF, COA, GMP |
Natural vs. Pharmaceutical Senolytics
| Approach | Compounds | Potency | Evidence Level | Risk Profile |
|---|---|---|---|---|
| Natural stack | Fisetin + Quercetin | Moderate | Phase 1/2 human pilots | Low |
| Pharmaceutical D+Q | Dasatinib + Quercetin | High | Multiple human trials (IPF, frailty) | Higher — physician required |
| Navitoclax (ABT-263) | BCL-XL inhibitor | Very High | Animal + early Phase 1 | Significant (thrombocytopenia) |
| Piperlongumine | Natural (pepper) | Emerging | Preclinical only | Unknown |
Natural senolytics are the appropriate first step for healthy adults interested in the longevity application without physician supervision. Pharmaceutical senolytics (D+Q) require medical supervision due to dasatinib’s drug interactions and navitoclax’s risk profile.
Who Should Consider a Senolytic Stack
Strong candidates:
- Adults 40+ interested in longevity science and cellular aging
- People already on a longevity stack (NMN, AKG, spermidine) looking to add senolytic clearance
- Those following Mayo Clinic, David Sinclair, or Peter Attia longevity protocols
- Anyone interested in fisetin or quercetin individually wanting the synergistic stack approach
Use caution or consult a physician:
- People on blood thinners or antiplatelet drugs — both fisetin and quercetin have mild anticoagulant activity
- Those on chemotherapy — BCL-2 targeting may interact with certain cancer treatments
- Individuals on immunosuppressants — immune modulation overlap
- Pregnant or breastfeeding women — insufficient safety data at senolytic doses
Related Articles
- Best Fisetin Supplement — Deep dive on fisetin alone
- Best Quercetin Supplement — Deep dive on quercetin alone
- Best Alpha-Ketoglutarate Supplement — AKG longevity companion
- Best NMN Supplement — NAD+ precursor for the longevity stack
- Best Spermidine Supplement — Autophagy induction post-senolysis
Frequently Asked Questions
What is the best natural senolytic supplement? For standalone use, fisetin is the most potent natural senolytic identified (Yousefzadeh et al., 2018). For a stack, combining fisetin with quercetin covers a broader range of senescent cell types via complementary BCL-2 family targeting. DoNotAge and Renue By Science offer the best dedicated senolytic stack products at appropriate doses.
How often should I take senolytics? Research-informed protocols use 2 consecutive days per month or per quarter. Daily low-dose use provides antioxidant benefits but not senolytic cell-clearing activity. The intermittent approach is the standard in the longevity community.
What are the best doses for a senolytic burst? Fisetin: 1,000–2,000mg per day for 2 consecutive days (equivalent to ~20mg/kg for a 75kg adult — the AFFIRM-LITE trial dose). Quercetin: 500–1,000mg per day on the same 2-day cycle. Take both with fat-containing meals to maximize polyphenol absorption.
Should I take fisetin and quercetin together or separately? Together on the same days. Their mechanisms are complementary — fisetin primarily targets BCL-2/BCL-W and quercetin adds BCL-XL inhibition. The combination achieves broader coverage of the anti-apoptotic proteins that different senescent cell populations rely on for survival. This is the rationale for combining them rather than using higher doses of one alone.
How do I know if senolytics are working? There is no simple consumer test for senescent cell burden. Proxy markers available via some longevity clinics include adipose tissue biopsy (p16/p21 staining — as used in AFFIRM-LITE), circulating inflammatory markers (IL-6, CRP, MMP-9), and epigenetic clock testing (Horvath or DunedinPACE). These are research tools, not routine tests. Most users in the longevity community track subjective markers (energy, inflammation, joint function) and longer-term clinical markers (blood biomarkers, DEXA scans).
Frequently Asked Questions
- Senolytics are compounds that selectively eliminate senescent cells — also called "zombie cells" — that have permanently stopped dividing but refuse to undergo programmed cell death (apoptosis). Senescent cells accumulate with aging and secrete a cocktail of inflammatory signaling molecules called the senescence-associated secretory phenotype (SASP), which damages neighboring healthy cells, drives chronic inflammation, and accelerates tissue aging. Senolytic compounds work by inhibiting the BCL-2 family of anti-apoptotic proteins that senescent cells rely on to survive, triggering their selective elimination while leaving healthy cells intact.
- Based on published research, the most potent natural senolytic combination is fisetin plus quercetin. A landmark 2018 study in EBioMedicine (Yousefzadeh et al., 2018; doi:10.1016/j.ebiom.2018.09.015) identified fisetin as the single most potent natural senolytic, clearing 25–50% of senescent cells in multiple tissues. Quercetin is frequently combined with fisetin or the pharmaceutical dasatinib (D+Q protocol). Together, fisetin and quercetin target overlapping BCL-2 family members through complementary pathways, providing broader coverage across different senescent cell types.
- Most longevity researchers use an intermittent senolytic protocol rather than daily dosing, because senolytics are designed to eliminate cells — not to be taken continuously. The most common natural senolytic protocol is 2 consecutive days per month (or per quarter) at high doses. Example — Fisetin 1000–2000mg + Quercetin 500–1000mg daily for 2 consecutive days, repeated monthly. This mirrors the preclinical senolytic research design. Lower daily maintenance doses (fisetin 100–250mg, quercetin 250–500mg) are used by some for ongoing antioxidant and anti-inflammatory benefits, but the senolytic (cell-clearing) mechanism requires high concentrations.
- The key human trial for fisetin is the AFFIRM-LITE trial by Mayo Clinic (Nora Bauer et al., 2021), a Phase 1/2 RCT in older adults that showed fisetin 20mg/kg for 2 days reduced senescent cell markers (p16, p21) in adipose tissue biopsies with no serious adverse events. For quercetin, the key human study is the Mayo Clinic dasatinib + quercetin (D+Q) trial in patients with idiopathic pulmonary fibrosis (Justice et al., 2019; doi:10.1016/j.ebiom.2019.03.053), which showed reduced SASP markers and improved physical function with 3 weeks of intermittent D+Q. Natural senolytics are earlier in the clinical pipeline than pharma-based approaches; the evidence is positive but preliminary.
- Both fisetin and quercetin have favorable safety profiles in available human data. The AFFIRM-LITE trial (fisetin) found no serious adverse events. Multiple quercetin trials up to 1000mg/day show good tolerability. The main concerns are potential interactions with blood thinners (both have mild antiplatelet activity), chemotherapy drugs (BCL-2 targeting may interfere with some cancer treatments), and immunosuppressants. The intermittent dosing protocol (2 days/month) rather than continuous use is the safety-conscious approach endorsed by most longevity researchers.